Cytopag Tablet 50 mg contains Eltrombopag Olamine, a potent thrombopoietin receptor agonist designed to increase platelet production in patients with low platelet counts. Low platelet levels, or thrombocytopenia, can lead to excessive bleeding and bruising and are commonly associated with conditions such as chronic immune thrombocytopenia (ITP), thrombocytopenia related to chronic hepatitis C, and severe aplastic anemia. Eltrombopag works by stimulating the thrombopoietin receptor on bone marrow cells, promoting the proliferation and maturation of megakaryocytes, which are responsible for producing platelets. Cytopag 50 mg is particularly suitable for patients requiring higher-dose therapy to achieve and maintain adequate platelet counts.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Cytopag Tablet 50 mg is indicated for:

• Chronic Immune Thrombocytopenia (ITP): For adults and children who do not adequately respond to conventional therapies such as corticosteroids or immunoglobulins.
• Thrombocytopenia due to Chronic Hepatitis C: Helps increase platelet counts to enable safe initiation or continuation of interferon-based antiviral therapy.
• Severe Aplastic Anemia: As an adjunctive treatment in patients unresponsive to immunosuppressive therapy.

Mechanism of Action

• Eltrombopag Olamine selectively binds to the thrombopoietin receptor (c-Mpl) on megakaryocyte precursors in the bone marrow.
• This stimulation accelerates megakaryocyte proliferation and differentiation, leading to increased platelet production.
• By enhancing platelet counts, Cytopag reduces the risk of spontaneous bleeding and supports the continuation of therapies that may otherwise be limited by thrombocytopenia.

Dosage and Administration

• Adults: Typically 50 mg once daily, with dose adjustments based on platelet response.
• Children: Dosage should be individualized according to body weight and clinical response.
• Take the tablet on an empty stomach or at least 2 hours before or 4 hours after meals, avoiding calcium-rich foods or supplements that can interfere with absorption.
• Regular monitoring of platelet counts, liver function, and complete blood counts is recommended during therapy.
• Do not exceed the prescribed dose without medical supervision.

Benefits

• Effectively increases platelet counts in patients with thrombocytopenia.
• Reduces risk of bleeding and associated complications.
• Enables continuation of treatments that may be interrupted due to low platelet levels.
• Improves overall quality of life for patients with chronic hematologic conditions.
• Convenient oral once-daily dosing allows for easy administration.

Side Effects

Common side effects may include:

• Headache
• Nausea or vomiting
• Fatigue
• Mild elevation of liver enzymes

Serious but rare side effects:

• Severe liver toxicity
• Thromboembolic events (blood clots)
• Cataracts or other eye changes
• Allergic reactions

Immediate medical attention is recommended if severe side effects or unusual bleeding occur.

Precautions

• Monitor liver function tests regularly.
• Use with caution in patients with a history of blood clots.
• Avoid sudden discontinuation without physician guidance.
• Inform your doctor of all medications and supplements, especially those containing calcium or polyvalent cations.
• Not recommended during pregnancy or breastfeeding unless advised by a healthcare professional.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Use in Special Populations

• Elderly: Monitor liver function and thrombotic risk.
• Pregnancy: Only under strict medical supervision.
• Renal or hepatic impairment: Dose adjustments may be required.

Storage

• Store below 30°C in a dry, cool place.
• Protect from light and moisture.
• Keep out of reach of children..